In the current study, we observed that patients with MS displayed significantly increased levels of IL-17 and TNF-α and notably reduced concentrations of anti-inflammatory cytokines and chemokines, such as IL-7, MIP-1α, and MIP-1β, compared with healthy subjects. This evidence concerns the gene IL7 and myeloid sarcoma.